Exeter Hospital

Exeter Hospital does not publicly identify a dedicated internal investment office. Since Beth Israel Lahey Health acquired its parent, Exeter Health Resources, in July 2023, capital allocation decisions are presumed to fall under BILH's centralized treasury and investment functions rather than being made locally at the hospital level.

Beth Israel Lahey Health (BILH) acquired Exeter Health Resources — Exeter Hospital's former parent company — effective July 1, 2023. The transaction made Exeter Hospital a fully integrated member of the BILH system, one of the largest healthcare networks in New England. Kevin Tabb, MD, President and CEO of BILH, serves on the hospital's board.

Yes. The Exeter Hospital Office of Philanthropy serves as the hospital's charitable fundraising arm. It is not organized as an independent foundation but rather as a department within the hospital structure, meaning its governance is ultimately tied to the hospital's board and, by extension, the BILH system.

Public records show that the hospital's asset base is dominated by commercial real estate holdings, including its main campus at 5 Alumni Drive and adjacent properties at 1, 4, 7, and 21 Hampton Road in Exeter, New Hampshire. It also maintains a self-insurance trust vehicle domiciled in Charlestown, Massachusetts. No meaningful marketable-securities portfolio is publicly disclosed.

Debra Cresta serves as President of Exeter Hospital. Rob Eberle is the Chair of the Board of Trustees. Kevin Tabb, MD, the President and CEO of Beth Israel Lahey Health, is a board member. Kevin Callahan, the former President and CEO of Exeter Health Resources, departed his role during the BILH acquisition integration.